Agape ATP Corp (ATPC) stock

ATPCNasdaqServices-Health ServicesFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 8/30

$1.27−0.09 (-6.62%)

Close on Nov 13, 2026Market cap $1.27MP/E –Yield –

Agape ATP r&d expenses

Research and development expenses are spending on new products and technology.

Agape ATP has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ATPC.

Revenue growth-20.3% · median -55.5%

Gross margin55.9% · median 25.5%

Operating margin-271.4% · median -34.7%

Net margin-100.2% · median -31.8%

Advertisement
300 × 250

See a number that looks wrong?